Issues of Vaccination During COVID

  • Issue of patent vs public health
  • India does not have enough production capacities which led to rise of second wave
  • Compulsory licensing,even if its issued there is no necessary capability to develop same vaccine by other companies
  • Data exclusivity: Even if vaccine waiver is provided but it does not lead to provision of research related information which can delay production of vaccine
  • Reduces private investment and innovation in future in case of Vaccine waiver
  • Lack of uniform vaccine pricing across all states causing Federal disputes
  • Issue of vaccine hesitancy
  • Vaccine diplomacy and scarcity of vaccines in India



India should increase its production capabilities

Global pooling of resources and compensation of private players for innovation and improve vaccine availability to all nation